[Hopespringpcsg] FW: Prostate Cancer Year-End Reading
Glen Tolhurst
glen46nor at gmail.com
Wed Jan 2 15:22:03 EST 2019
Hi all:
Below is information passed to me by one of the other PCCN groups.
Take care,
Glen
1) Prostate Cancer Canada - Annual Impact Report
<https://prostatecancer.us2.list-manage.com/track/click?u=381dca877e43c44046
caa6dd1&id=8ff431c943&e=f682fa5e10> 2017/18 Annual Impact Report
2) Check out video from the Us TOO Prostate Cancer Pathways for Patients
and Caregivers educational event and webcast recorded on September 29 at
Englewood Health in Englewood, NJ. Presentation topics include:
. Prostate Cancer and Sexuality
. Advanced Stage Disease and Immunotherapy
. Screening, Staging and Treatment of Localized Disease
. Integrative Medicine
. Meditation
. Prostate Cancer 101
. Men's Health
<http://r20.rs6.net/tn.jsp?f=001om2yRMeqxQWYuJ3QScnB76N-jXT-a6ytSDHjyRP3JGOS
t9BRJNtj-fAkD5q2JcfAoD-jUJZc6Br4nhrOSAQSVQ_dH95KEmzUVRhC7YPNYDTIPiehB8gEEM8c
S6SLne_oZ0COjlqURjQcw0hDP9R8hfd0K-1rn-owqZVfzBS7wQA=&c=Dp5Gt1IBifkk61XWNUQsY
ugyvHDdNn5itEn_xdFwwuXMJDqtbE7_hw==&ch=FmCBF7akDAEmzU2thfC--P6REm8cAP0heYfvp
tORxW8zXtDfZoTeig==> CLICK HERE for access direct links to short video
segments specific to each topic or watch the entire presentation.
3) From psa-rising.com website December 2018
A large new study of 87,346 patients on androgen deprivation therapy for
advanced prostate cancer finds can extend life and decrease death from
prostate cancer.
Renal and Urology News sums up: "Statin use independently predicted a
significant 34% decreased risk of death from any cause, 44% decreased risk
of death from PCa, and 36% decreased risk of skeletal-related events, after
adjusting for multiple potential confounders, including age, race, Charlson
comorbidity index (CCI), Gleason score, and PSA."
Study authors conclude: "The use of statins in men on ADT for castrate
resistant prostate cancer [CAP] is associated with improved CSS (i.e.
decreased death from the cancer] and OS [Overall Survival]. Statins are
inexpensive, well-tolerated medications that offer a promising adjunct to
ADT, but require further prospective studies." This study was funded by the
US Department of Defense
https://www.ncbi.nlm.nih.gov/pubmed/30528885?fbclid=IwAR0x53gXMsnCl-uOOscf4P
z_D3RF4T7-PJyiIHxSTGRDG89mFyahcDTnu8Q
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://artsservices.uwaterloo.ca/pipermail/hopespringpcsg/attachments/20190102/4bd2f446/attachment.html>
More information about the Hopespringpcsg
mailing list